Approval · Notice of Compliance 14884 · 2013
OPSUMIT: Notice of Compliance 14884
Issued November 6, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14884
- Date
- November 6, 2013
- Company
- Actelion Pharmaceuticals LtdAllschwil, Basel-Landschaft, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Endothelin receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPSUMIT | 02415690 | Marketed |
Medicinal ingredients
- MACITENTAN 10 MG per TAB